Nehul S - Search Results

1

Disruption of Molecular Interactions between the G3BP1 Stress Granule Host Protein and the Nucleocapsid (NTD-N) Protein Impedes SARS-CoV-2 Virus Replication.

Dhaka P, Singh A, Nehul S, Choudhary S, Panda PK, Sharma GK, Kumar P, Tomar S. Dhaka P, et al. Among authors: nehul s. Biochemistry. 2024 Dec 21. doi: 10.1021/acs.biochem.4c00536. Online ahead of print. Biochemistry. 2024. PMID: 39708056

2

Designing and bioengineering of CDRs with higher affinity against receptor-binding domain (RBD) of SARS-CoV-2 Omicron variant.

Singh V, Choudhary S, Bhutkar M, Nehul S, Ali S, Singla J, Kumar P, Tomar S. Singh V, et al. Among authors: nehul s. Int J Biol Macromol. 2024 Dec 13;290:138751. doi: 10.1016/j.ijbiomac.2024.138751. Online ahead of print. Int J Biol Macromol. 2024. PMID: 39675603

3

Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody.

Singh V, Bhutkar M, Choudhary S, Nehul S, Kumar R, Singla J, Kumar P, Tomar S. Singh V, et al. Among authors: nehul s. Biochem Biophys Res Commun. 2024 Nov 19;734:150746. doi: 10.1016/j.bbrc.2024.150746. Epub 2024 Sep 26. Biochem Biophys Res Commun. 2024. PMID: 39366179

4

Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease.

Choudhary S, Nehul S, Singh A, Panda PK, Kumar P, Sharma GK, Tomar S. Choudhary S, et al. Among authors: nehul s. IUBMB Life. 2024 May;76(5):228-241. doi: 10.1002/iub.2793. Epub 2023 Dec 7. IUBMB Life. 2024. PMID: 38059400

5

A retrospective study showing a high rate of seropositivity against SARS-CoV-2 in wild felines in India.

Borkakoti R, Karikalan M, Nehul SK, Jogi HR, Sharma K, Nautiyal S, Mishra R, Mahajan S, Biswas SK, Nandi S, Chander V, Pawde A, Saikumar G, Singh KP, Sharma GK. Borkakoti R, et al. Among authors: nehul sk. Arch Virol. 2023 Mar 13;168(4):109. doi: 10.1007/s00705-023-05735-4. Arch Virol. 2023. PMID: 36914777 Free PMC article.

6

Identification and evaluation of antiviral potential of thymoquinone, a natural compound targeting Chikungunya virus capsid protein.

Kumar R, Nehul S, Singh A, Tomar S. Kumar R, et al. Among authors: nehul s. Virology. 2021 Sep;561:36-46. doi: 10.1016/j.virol.2021.05.013. Epub 2021 Jun 10. Virology. 2021. PMID: 34146962 Free article.

7

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.

Mudgal R, Nehul S, Tomar S. Mudgal R, et al. Among authors: nehul s. Hum Vaccin Immunother. 2020 Dec 1;16(12):2921-2931. doi: 10.1080/21645515.2020.1805992. Epub 2020 Sep 15. Hum Vaccin Immunother. 2020. PMID: 32931361 Free PMC article. Review.

8

Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection.

Fatma B, Kumar R, Singh VA, Nehul S, Sharma R, Kesari P, Kuhn RJ, Tomar S. Fatma B, et al. Among authors: nehul s. Antiviral Res. 2020 Jul;179:104808. doi: 10.1016/j.antiviral.2020.104808. Epub 2020 May 4. Antiviral Res. 2020. PMID: 32380148

9

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity-mediating antibodies in HIV-infected Indian individuals.

Nehul S, Kulkarni A, Pawar S, Godbole S, Ghate M, Thakar M. Nehul S, et al. Infect Dis (Lond). 2018 Jan;50(1):35-43. doi: 10.1080/23744235.2017.1361547. Epub 2017 Aug 4. Infect Dis (Lond). 2018. PMID: 28776433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters